Categorie -wet- en regelgeving

bv CGR, GDPR

wet- en regelgeving

AstraZeneca’s Lynparza scores limited NICE backing for new first-line maintenance use

29 juli 2019

FiercePharma

wet- en regelgeving

Vertex files cystic fibrosis triple therapy with FDA

24 juli 2019

PMLiVE

wet- en regelgeving

FDA approves Pfizer’s biosimilar version of Genentech’s Rituxan

24 juli 2019

InPharm.com

wet- en regelgeving

Humira biosimilar from Samsung Bioepis and MSD wins marketing authorisation in the US

24 juli 2019

InPharm.com

wet- en regelgeving

RNAi Therapy for Homozygous Familial Hypercholesterolemia Gets Orphan Drug Designation

18 juli 2019

Monthly Prescribing Reference (MPR): Drugs in the Pipeline

wet- en regelgeving

FDA approves MSD’s combo therapy Recarbrio for urinary tract and intra-abdominal infections

18 juli 2019

InPharm.com

Medhc-fases-banner

Advertentie(s)

Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer